The facts that they have already signed contract with few sites in Germany and NL, Revenue has already generated not like other biotech that just in a pre-commercialisation phrase, I am confident that the list will just keep growing.CE approval is also highly likely in EU, so AUS will eventually follow, Risk of success if very low, IMO
Ann: Top 20 Holders, page-3
Add IMR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.0¢ |
Change
0.030(6.82%) |
Mkt cap ! $95.34M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 47.0¢ | 41.5¢ | $178.5K | 394.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16118 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.0¢ | 21837 | 2 |
View Market Depth
| Last trade - 16.10pm 28/05/2024 (20 minute delay) ? |
|
|||||
|
Last
46.0¢ |
Change
0.030 ( 8.24 %) |
||||
| Open | High | Low | Volume | ||
| 42.0¢ | 47.0¢ | 41.5¢ | 36623 | ||
| Last updated 15.58pm 28/05/2024 ? | |||||
| IMR (ASX) Chart |